A JOURNEY FROM BECOMING A DIABETES TYPE 1 PATIENT TO REALIZING A CE-MARKED ARTIFICIAL PANCREAS

Robin Koops^1,2

¹Diabetes type 1 patient, Diabetes Fund, the Netherlands; ²Inreda Diabetic B.V., The Netherlands

THE WORLD APHERESIS ASSOCIATION APHERESIS REGISTRY REPORT: AN UPDATE UNTIL 2024

Bernd Stegmayr¹, Elizabeth newman², Volker Witt³, Kurt Derfler⁴, Dries Deeren⁵, Ines Bojanic⁶, Zdenka Gasova⁷, Zdenka Bhuiyan-Ludvikova⁷, Milan Blaha⁸, Mirka Lanska⁸, Sarka Blahutoca⁹, Jan Kielstein¹⁰, Heinrich Prophet¹¹, Judita Audzijoniene¹², Antanas Griskevicius¹², Hans Vrielink¹³, Kaatje LePoole¹³, Astrid Aandahl¹⁴, Tanya Glatt¹⁵, Rosita Bihariesingh¹⁶, Gunilla Welander¹⁷, Gösta Berlin¹⁸, Ana Maria Vasilache¹⁸, Josefina Dykes¹⁹, Sofia Smargianaki¹⁹, Matthias Hellberg¹⁹, Carin Wallquist²⁰, Virginia Strineholm²¹, Fredrik Toss²², Michael Ott²², Emma Watz²³, Thomas Nilsson²³, Guldane Cengiz Seval²⁴, Selami Kocak Topra²⁴

¹Umea University, Sweden; ²Concord Repatriation General Hospital, Concord, Australia; ³St Anna University Hospital, Vienna, Austria; ⁴Athos Institute, Vienna; ⁵H.-Hartziekenhuis Roeselare-Menen, Roeselare, Belgium; ⁶Kbc, University Hospital, Zagreb, Croatia; ⁷Inst. Hematology and Blood Transfusion, Prague, Czech Republic; ⁸Charles University, Hradec Kralove, Czech Republic; ⁹University Hospital, Ostrava, Czech Republic; ¹⁰University Hospital, Braunschweig, Germany; ¹¹Nephrocare MVZ, Rostock, Germany; ¹²University Hospital, Vilnius, Lithuania; ¹³Sanquin, The Netherlands; ¹⁴University Hospital, Akershus, Norway; ¹⁵Sanquin, Johannesburg, South Africa; ¹⁶University Hospital, Paramaribo, Suriname; ¹⁷Central Hospital, Karlstad, Sweden; ¹⁸University Hospital, Linköping, Sweden; ¹⁹University Hospital, Lund, Sweden; ²⁰University Hospital, Malmö, Sweden; ²¹University Hospital, Örebro, Sweden; ²²University Hospital, Umea, Sweden; ²³University Hospital, Uppsala, Sweden; ²⁴University Hospital, Ankara, Turkey

IN VITRO CHARACTERIZATION OF NOVEL ‘PEPTIDE Β’

Josefin Soppert, Giulia Bagarolo, Emona Staudacher, Marie-Luise Berres, Joachim Jankowski, Heidi Noels

University Hospital RWTH Aachen, Germany

MIMICKING LIVER MICROENVIRONMENT IN A 3D IN VITRO MODEL: COLLAGEN HYDROGELS FUNCTIONALIZED WITH FIBRONECTIN

Estela Sanchez-Gonzalez^1,2, Manuel Salmeron-Sanchez^1,2,3, Gloria Gallego-Ferrer^1,2, Laia Tolosa^3,4

¹Centre for Biomaterials and Tissue Engineering, Polytechnic University of Valencia, Spain; ²Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valencia, Spain; ³Centre for the Cellular Microenvironment, University of Glasgow, Glasgow, United Kingdom; ⁴Experimental Hepatology Unit, Health Research Institute La Fe (IIS La Fe), Valencia, Spain

Resveralogues protect HepG2 cells against cellular senescence induced by hepatotoxic metabolites

Neda Heidari, Richard Faragher, Susan Sandeman

University of Brighton, United Kingdom

Cryopreservation of in vitro liver model using HepaRG cells for toxicological studies

Carla Meschini¹, Eric Leclerc², Yasuyuki Sakai², Cécile Legallais¹, Ulysse Pereira¹

¹Université de Technologie de Compiègne, France; ²University of Tokyo, Japan